Garrison Point Advisors LLC Sells 47 Shares of UnitedHealth Group Incorporated (NYSE:UNH)

Garrison Point Advisors LLC lowered its position in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 1.7% in the second quarter, HoldingsChannel reports. The fund owned 2,646 shares of the healthcare conglomerate’s stock after selling 47 shares during the period. Garrison Point Advisors LLC’s holdings in UnitedHealth Group were worth $1,348,000 at the end of the most recent quarter.

Several other hedge funds have also added to or reduced their stakes in the company. Bell Investment Advisors Inc increased its holdings in UnitedHealth Group by 4.8% in the fourth quarter. Bell Investment Advisors Inc now owns 525 shares of the healthcare conglomerate’s stock valued at $276,000 after purchasing an additional 24 shares during the last quarter. Harbor Investment Advisory LLC raised its position in shares of UnitedHealth Group by 3.2% in the 1st quarter. Harbor Investment Advisory LLC now owns 35,946 shares of the healthcare conglomerate’s stock valued at $17,783,000 after acquiring an additional 1,129 shares during the period. Austin Private Wealth LLC grew its holdings in UnitedHealth Group by 9.8% during the first quarter. Austin Private Wealth LLC now owns 1,246 shares of the healthcare conglomerate’s stock valued at $573,000 after purchasing an additional 111 shares during the period. Capital Insight Partners LLC boosted its position in shares of UnitedHealth Group by 3.8% during the first quarter. Capital Insight Partners LLC now owns 9,045 shares of the healthcare conglomerate’s stock worth $4,475,000 after purchasing an additional 332 shares in the last quarter. Finally, Collective Family Office LLC grew its holdings in shares of UnitedHealth Group by 4.3% in the 1st quarter. Collective Family Office LLC now owns 1,577 shares of the healthcare conglomerate’s stock valued at $780,000 after buying an additional 65 shares during the period. Institutional investors own 87.86% of the company’s stock.

Analyst Upgrades and Downgrades

A number of research firms have issued reports on UNH. UBS Group boosted their target price on UnitedHealth Group from $640.00 to $680.00 and gave the company a “buy” rating in a research note on Thursday, July 18th. StockNews.com cut UnitedHealth Group from a “buy” rating to a “hold” rating in a research note on Monday. Baird R W upgraded shares of UnitedHealth Group to a “strong-buy” rating in a report on Thursday, May 30th. Robert W. Baird upped their target price on shares of UnitedHealth Group from $597.00 to $640.00 and gave the stock an “outperform” rating in a research note on Wednesday, July 17th. Finally, HSBC lifted their price target on UnitedHealth Group from $580.00 to $610.00 in a research note on Thursday, July 18th. Two analysts have rated the stock with a hold rating, eighteen have given a buy rating and one has issued a strong buy rating to the company’s stock. Based on data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and a consensus price target of $614.17.

UnitedHealth Group Trading Up 0.8 %

UNH stock opened at $599.04 on Wednesday. The stock has a market cap of $553.17 billion, a price-to-earnings ratio of 36.62, a price-to-earnings-growth ratio of 1.66 and a beta of 0.58. The company has a fifty day moving average price of $562.99 and a two-hundred day moving average price of $516.05. UnitedHealth Group Incorporated has a one year low of $436.38 and a one year high of $607.94. The company has a debt-to-equity ratio of 0.67, a current ratio of 0.88 and a quick ratio of 0.88.

UnitedHealth Group (NYSE:UNH) last posted its earnings results on Tuesday, July 16th. The healthcare conglomerate reported $6.80 EPS for the quarter, beating the consensus estimate of $6.66 by $0.14. UnitedHealth Group had a return on equity of 26.55% and a net margin of 3.66%. The company had revenue of $98.86 billion for the quarter, compared to the consensus estimate of $98.73 billion. During the same quarter in the prior year, the business earned $6.14 earnings per share. The firm’s revenue for the quarter was up 6.4% on a year-over-year basis. Equities analysts anticipate that UnitedHealth Group Incorporated will post 27.69 EPS for the current year.

UnitedHealth Group Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Tuesday, September 24th. Shareholders of record on Monday, September 16th will be given a dividend of $2.10 per share. The ex-dividend date of this dividend is Monday, September 16th. This represents a $8.40 dividend on an annualized basis and a dividend yield of 1.40%. UnitedHealth Group’s payout ratio is presently 51.34%.

Insider Activity

In other UnitedHealth Group news, CAO Thomas E. Roos sold 2,851 shares of the firm’s stock in a transaction on Wednesday, July 17th. The stock was sold at an average price of $569.88, for a total transaction of $1,624,727.88. Following the transaction, the chief accounting officer now owns 29,501 shares in the company, valued at approximately $16,812,029.88. The transaction was disclosed in a filing with the SEC, which is available through this hyperlink. In other UnitedHealth Group news, EVP Erin Mcsweeney sold 1,500 shares of the company’s stock in a transaction on Thursday, July 18th. The stock was sold at an average price of $579.03, for a total transaction of $868,545.00. Following the completion of the sale, the executive vice president now directly owns 7,785 shares in the company, valued at $4,507,748.55. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, CAO Thomas E. Roos sold 2,851 shares of the business’s stock in a transaction on Wednesday, July 17th. The stock was sold at an average price of $569.88, for a total value of $1,624,727.88. Following the transaction, the chief accounting officer now directly owns 29,501 shares of the company’s stock, valued at approximately $16,812,029.88. The disclosure for this sale can be found here. 0.33% of the stock is owned by company insiders.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.